HomeCompareCIHPF vs MRK

CIHPF vs MRK: Dividend Comparison 2026

CIHPF yields 8.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIHPF wins by $102671.65M in total portfolio value
10 years
CIHPF
CIHPF
● Live price
8.00%
Share price
$0.25
Annual div
$0.02
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102671.71M
Annual income
$100,264,061,475.17
Full CIHPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CIHPF vs MRK

📍 CIHPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIHPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIHPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIHPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIHPF
Annual income on $10K today (after 15% tax)
$680.00/yr
After 10yr DRIP, annual income (after tax)
$85,224,452,253.89/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CIHPF beats the other by $85,224,443,657.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIHPF + MRK for your $10,000?

CIHPF: 50%MRK: 50%
100% MRK50/50100% CIHPF
Portfolio after 10yr
$51335.88M
Annual income
$50,132,035,794.48/yr
Blended yield
97.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CIHPF
No analyst data
Altman Z
1.0
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIHPF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIHPFMRK
Forward yield8.00%2.81%
Annual dividend / share$0.02$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$102671.71M$57.7K
Annual income after 10y$100,264,061,475.17$10,113.78
Total dividends collected$102507.33M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIHPF vs MRK ($10,000, DRIP)

YearCIHPF PortfolioCIHPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,300$1,600.00$11,213$373.04+$1.1KCIHPF
2$16,840$3,678.50$12,667$512.06+$4.2KCIHPF
3$27,432$9,413.30$14,439$708.14+$13.0KCIHPF
4$58,014$28,662.18$16,640$988.16+$41.4KCIHPF
5$175,377$113,301.94$19,432$1,394.07+$155.9KCIHPF
6$827,865$640,211.40$23,057$1,992.90+$804.8KCIHPF
7$6,534,621$5,648,805.61$27,889$2,894.79+$6.51MCIHPF
8$90,334,040$83,341,996.20$34,518$4,286.29+$90.30MCIHPF
9$2,250,139,007$2,153,481,584.22$43,912$6,494.35+$2250.10MCIHPF
10$102,671,710,213$100,264,061,475.17$57,714$10,113.78+$102671.65MCIHPF

CIHPF vs MRK: Complete Analysis 2026

CIHPFStock

CB Industrial Product Holding Berhad, an investment holding company, manufactures and sells palm oil mill equipment and related spare parts in Indonesia, Malaysia, Papua New Guinea, Central America, Africa, Liberia, and internationally. The company operates through Plantation and Milling, Equipment and Engineering, Refinery, Special Purpose Vehicles, and Investing segments. Its products include screw presses, digesters, sludge centrifuges, and king crackers. The company also cultivates oil palm; and engages in trading and processing crude palm oil, crude palm kernel oil, sludge palm oil, and refined bleached deodorized palm oil. In addition, it is involved in designing, fabricating, manufacturing, retrofitting, and maintaining works of various special purpose vehicles, such as firefighting and rescue vehicles, and ambulances. Further, the company designs, manufactures, installs, tests, commissions, and maintains works of boilers and unfired pressure vessels. Additionally, it engages in the provision of services for engineering support, mechanical fabrication, commissioning, and other contracting works for palm oil mills; trading of palm oil mill processing equipment; supply and sale of spare parts for palm oil mills; and design, fabrication, supply, procurement, maintenance, and service of aviation related equipment. CB Industrial Product Holding Berhad was founded in 1980 and is based in Shah Alam, Malaysia.

Full CIHPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CIHPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIHPF vs SCHDCIHPF vs JEPICIHPF vs OCIHPF vs KOCIHPF vs MAINCIHPF vs JNJCIHPF vs ABBVCIHPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.